Drug Detail:Qulipta (Atogepant [ a-toe-je-pant ])
Generic Name: ATOGEPANT 10mg
Dosage Form: tablet
Drug Class: CGRP inhibitors
Drug Detail:Qulipta (Atogepant [ a-toe-je-pant ])
Generic Name: ATOGEPANT 10mg
Dosage Form: tablet
Drug Class: CGRP inhibitors
QULIPTA is taken orally with or without food.
Episodic Migraine
The recommended dosage of QULIPTA for episodic migraine is 10 mg, 30 mg, or 60 mg taken once daily.
Chronic Migraine
The recommended dosage of QULIPTA for chronic migraine is 60 mg taken once daily.
Dosing modifications for concomitant use of specific drugs and for patients with renal impairment are provided in Table 1.
Dosage Modifications | Recommended Once Daily Dosage for Episodic Migraine |
Usage and Recommended Once Daily Dosage for Chronic Migraine |
Concomitant Drug [see Drug Interactions (7)] | ||
Strong CYP3A4 Inhibitors (7.1) | 10 mg | Avoid use |
Strong, Moderate, or Weak CYP3A4 Inducers (7.2) | 30 mg or 60 mg | Avoid use |
OATP Inhibitors (7.3) | 10 mg or 30 mg | 30 mg |
Renal Impairment [see Use in Specific Populations (8)] | ||
Severe Renal Impairment and End-Stage Renal Disease (CLcr <30 mL/min) (8.6) | 10 mg | Avoid use |